Next Oncology-Dallas

Irving, Texas 75039

17 studies enrolling now · 24 studies all time

What they study most

Adenocarcinoma of Esophagus, Advanced Cancer, Advanced Solid Malignancies, Advanced Solid Tumor, Advanced Solid Tumors, Anogenital Cancer, Biliary Tract Carcinoma, Bladder Cancer, Breast Cancer, CNS Tumor, CRC, Cervical Squamous Cell Carcinoma

Studies at this site

• AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors — Recruiting now
• Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer — Recruiting now
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — Recruiting now
• Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors — Recruiting now
• A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer — Recruiting now
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers — Recruiting now
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors — Recruiting now
• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC — Recruiting now
• Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors — Recruiting now
• A Study of PHST001 in Advanced Solid Tumors — Recruiting now
• First in Human Study of TUB-030 in Patients With Advanced Solid Tumors — Recruiting now
• FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC — Recruiting now
• A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies — Recruiting now
• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors — Recruiting now
• A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors — Recruiting now
• Study of APR-1051 in Patients With Advanced Solid Tumors — Recruiting now
• Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies — Recruiting now
• Study Of ATRN-119 In Patients With Advanced Solid Tumors — Completed
• A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors — Stopped early
• Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications — Stopped early
• A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer — Running, not enrolling
• A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors — Stopped early
• A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Running, not enrolling
• Safety and Tolerability of Intravenous Administration of ICVB-1042 — Stopped early